Medical Device News Magazine

Topcon Healthcare and OphtAI Announce their Partnership in EMEA

About Medical Device News Magazine

About Medical Device News Magazine. We are a digital publication founded in 2008 located in the United States.

Advertise with Medical Device News Magazine! Join Our #1 Family of Advertisers!

We pride ourselves on being the best-kept secret when it comes to distributing your news! Our unique digital approach enables us to circulate your...

Topcon Healthcare Solutions EMEA Oy (Topcon Healthcare), a leading provider of medical devices and software solutions for the global eye care community, and OphtAI, a joint venture specialised in Artificial Intelligence (AI) for ophthalmology, are pleased to announce their partnership. The partnership will see OphtAI integrated into Topcon’s vendor-neutral data management solution, Harmony Referral System (Harmony), and provide eye care professionals smarter access to AI services.

The state-of-the-art OphtAI Artificial Intelligence algorithm assists eye care professionals in detecting eye pathologies such as diabetic retinopathy and its gradation, macular edema, glaucoma, and AMD at an early stage within only a few seconds, and with only one colour fundus image.

As a result of the partnership, eye care professionals can now enjoy access to OphtAI from Harmony, regardless of which colour fundus device they might be using. Topcon Harmony is a vendor-neutral data management platform, meaning it can be connected to any device, regardless of manufacturer. Harmony gives eye care professionals the flexibility to choose the best devices for their business whilst simultaneously streamlining their clinical workflow by facilitating a single-screen review of all data. Harmony supports vendor-neutral connectivity to devices and Patient Management Systems (PMS) as well as other 3rd party software solutions, providing eye care professionals with workflows designed to answer the specific needs of their clinic or organisation. For Topcon, the partnership with OphtAI strengthens the already existing AI service portfolio that is offered via the platform’s Artificial Intelligence (AI) Marketplace. Through the AI Marketplace, Harmony customers can choose their preferred AI partner and access the automatic image analysis tool of their choice with one single click, straight from the Harmony viewer.

”At Topcon Healthcare, we provide eye care professionals globally with access to innovative solutions for enhanced patient care and effective workflows. This partnership with OphtAI provides our customers with another solution that can help improve efficiency and drive better patient outcomes by making the latest technology an accessible and easy to use part of their everyday workflow.” states Riina Rautee, Director, Sales & Business Development, EMEA for Topcon Healthcare.

”To fully unleash the potential of Artificial Intelligence within the eye care industry, it has to be smartly integrated into the tools that eye care professionals use daily in their clinical workflow. From that perspective, the integration of OphtAI into Harmony is a success. It enables us to bring AI as close as possible to the patients that need it and deliver a higher value proposition to the Optometrists and Ophthalmologists by utilising Topcon’s solutions.” says Alexandre Le Guilcher, OphtAI CEO.

Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine provides breaking medical device / biotechnology news. Our subscribers include medical specialists, device industry executives, investors, and other allied health professionals, as well as patients who are interested in researching various medical devices. We hope you find value in our easy-to-read publication and its overall objectives! Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

Other News

Shoulder Innovations Further Strengthens IP Portfolio in Key Areas with Recent Patent Grants

"These recent grants further strengthen key patent families that are foundational to our technology, and we are pleased the USPTO continues to recognize our meaningful innovation in the shoulder arthroplasty segment," said Rob Ball, CEO of Shoulder Innovations. "This noteworthy expansion of our IP position represents the culmination of over 10 years of research and development, and we are proud of our team for their continued dedication to creating practical solutions for shoulder surgeons and advancing patient outcomes."

Radical Catheter Technologies Presents Analysis of Disruptive, Recently FDA-Cleared Endovascular Technology at the Society of NeuroInterventional Surgery 21st Annual Meeting

This new catheter, the first product commercialized from this novel technology platform, is designed to enable access to the blood vessels in the brain for both femoral and radial access. A multi-center analysis of this disruptive technology is being presented today at Society of NeuroInterventional Surgery 21st annual meeting. In addition, the Company confirmed the closing of a $20 million financing round led by NeuroTechnology Investors, which will be used to scale the company and expand the Radical platform notes Radical Catheter Technologies.

Rapid Medical™ Completes Initial Neurovascular Cases in the USA Following FDA Clearance of Its Active Access Solution

“With DRIVEWIRE, our design goal was to bring new levels of access and control to the interventional suite while improving best-in-class guidewires,” comments Giora Kornblau, Chief Technology Officer at Rapid Medical. “When physicians are looking for technologies that increase the clinical possibilities and safety for the patient, we want Rapid to be the first place they look.”